Bank of Nova Scotia’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.19M Sell
11,974
-2,402
-17% -$650K 0.01% 667
2025
Q4
$3.61M Buy
14,376
+2,724
+23% +$723K 0.01% 695
2025
Q3
$3.34M Buy
11,652
+1,497
+15% +$401K 0.01% 620
2025
Q2
$2.67M Buy
10,155
+192
+2% +$46.8K 0.01% 621
2025
Q1
$2.32M Sell
9,963
-17,712
-64% -$4.3M 0.01% 587
2024
Q4
$6.35M Buy
27,675
+15,420
+126% +$3.54M 0.01% 488
2024
Q3
$2.74M Sell
12,255
-40,514
-77% -$8.9M 0.01% 590
2024
Q2
$10.7M Buy
52,769
+41,005
+349% +$8.34M 0.02% 357
2024
Q1
$2.57M Sell
11,764
-163,412
-93% -$36M 0.01% 611
2023
Q4
$39.8M Buy
175,176
+165,528
+1,716% +$34.8M 0.07% 186
2023
Q3
$1.94M Sell
9,648
-2,000
-17% -$422K 0.01% 589
2023
Q2
$2.08M Buy
11,648
+2,798
+32% +$543K 0.01% 517
2023
Q1
$1.74M Sell
8,850
-1,354
-13% -$279K 0.01% 577
2022
Q4
$2.06M Sell
10,204
-165
-2% -$32.2K 0.01% 633
2022
Q3
$1.82M Sell
10,369
-3,452
-25% -$707K 0.01% 659
2022
Q2
$2.78M Sell
13,821
-24,040
-63% -$5.12M 0.01% 620
2022
Q1
$8.58M Sell
37,861
-49,037
-56% -$11.5M 0.01% 485
2021
Q4
$23.5M Buy
86,898
+45,688
+111% +$11.3M 0.03% 357
2021
Q3
$9.96M Sell
41,210
-14,883
-27% -$3.75M 0.02% 481
2021
Q2
$13.3M Buy
56,093
+17,249
+44% +$3.93M 0.02% 384
2021
Q1
$8.51M Sell
38,844
-108,660
-74% -$21.8M 0.02% 442
2020
Q4
$25.8M Buy
147,504
+70,221
+91% +$12.1M 0.05% 259
2020
Q3
$12.5M Sell
77,283
-82,454
-52% -$13.1M 0.03% 320
2020
Q2
$22.8M Buy
159,737
+108,000
+209% +$14.9M 0.08% 198
2020
Q1
$5.62M Buy
51,737
+12,793
+33% +$1.84M 0.02% 403
2019
Q4
$5.66M Buy
38,944
+27,184
+231% +$3.92M 0.01% 502
2019
Q3
$1.7M Sell
11,760
-7,749
-40% -$1.13M 0.01% 691
2019
Q2
$2.9M Sell
19,509
-5,866
-23% -$818K 0.01% 535
2019
Q1
$3.34M Sell
25,375
-2,970
-10% -$366K 0.01% 523
2018
Q4
$3.08M Sell
28,345
-62,165
-69% -$8.33M 0.01% 502
2018
Q3
$13.5M Buy
90,510
+77,484
+595% +$11.8M 0.06% 261
2018
Q2
$2.01M Sell
13,026
-2,127
-14% -$321K 0.01% 502
2018
Q1
$2.11M Sell
15,153
-3,401
-18% -$500K 0.01% 553
2017
Q4
$2.54M Sell
18,554
-2,079
-10% -$275K 0.01% 545
2017
Q3
$2.68M Sell
20,633
-6,193
-23% -$826K 0.02% 503
2017
Q2
$3.55M Sell
26,826
-437
-2% -$53.5K 0.02% 493
2017
Q1
$3.36M Buy
27,263
+24,608
+927% +$2.91M 0.01% 493
2016
Q4
$293K Buy
2,655
+244
+10% +$27.1K ﹤0.01% 706
2016
Q3
$285K Sell
2,411
-110,545
-98% -$13M ﹤0.01% 615
2016
Q2
$12.6M Buy
112,956
+110,755
+5,032% +$11.9M 0.07% 135
2016
Q1
$221K Buy
2,201
+12
+0.5% +$1.15K ﹤0.01% 646
2015
Q4
$233K Sell
2,189
-24
-1% -$2.48K ﹤0.01% 664
2015
Q3
$206K Buy
2,213
+24
+1% +$2.48K ﹤0.01% 630
2015
Q2
$228K Buy
2,189
+128
+6% +$13.3K ﹤0.01% 555
2015
Q1
$223K Buy
+2,061
New +$212K ﹤0.01% 550

Other funds holding LH

Bank of Nova Scotia's LH Position: Q1 2026 in Review

Bank of Nova Scotia reduced its Labcorp (LH) stake by 17% in Q1 2026, selling an estimated $650K and leaving 11,974 shares worth $3.19M. The position accounts for 0.01% of the portfolio, ranked #667.

Bank of Nova Scotia first reported a position in LH in Q1 2015 and has held it in 45 quarters since. The position peaked at $39.8M in Q4 2023. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Bank of Nova Scotia held 11,974 shares of Labcorp worth $3.19M as of Q1 2026.
  • Bank of Nova Scotia sold 2,402 Labcorp shares in Q1 2026, an estimated $650K.
  • Labcorp made up 0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #667 holding.
  • Bank of Nova Scotia first reported a position in Labcorp in Q1 2015 and has held it in 45 quarters since.
  • Bank of Nova Scotia's Labcorp position peaked at $39.8M in Q4 2023.
  • 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.